Purpuromycin: An antibiotic inhibiting tRNA aminoacylation. Kirillov, S., Vitali, L., Goldstein, B., Monti, F., Semenkov, Y., Makhno, V., Ripa, S., Pon, C., & Gualerzi, C. RNA, 3(8):905-913, 1997. cited By 27
Purpuromycin: An antibiotic inhibiting tRNA aminoacylation [link]Paper  abstract   bibtex   
Purpuromycin, an antibiotic produced by Actinoplanes lanthinogenes, had been reported previously to inhibit protein synthesis. In the present report, we demonstrate that the mechanism of action of this antibiotic is quite novel in that it binds with fairly high affinity to all tRNAs, inhibiting their acceptor capacity. Although more than one molecule of purpuromycin is bound to each tRNA molecule, the inhibitory activity of this antibiotic was found to be selective for the tRNA acceptor function; in fact, after the aminoacylation step, purpuromycin was found to affect none of the other tested functions of tRNA (interaction with the ribosomal P- and A-sites and interaction with translation factors). Accordingly, purpuromycin was found to inhibit protein synthesis only when translation depended on the aminoacylation of tRNA and not when the system was supplemented with pre- formed aminoacyl-tRNAs. Because purpuromycin did not interfere with the ATP- PP(1) exchange reaction of the synthetase or with the initial interaction of the enzyme with its tRNA substrate, the basis for the inhibition of aminoacylation is presumably the formation of a nonproductive synthetase- tRNA complex in the presence of purpuromycin in which the tRNA is unable to be charged with the corresponding amino acid.
@ARTICLE{Kirillov1997905,
author={Kirillov, S. and Vitali, L.A. and Goldstein, B.P. and Monti, F. and Semenkov, Y. and Makhno, V. and Ripa, S. and Pon, C.L. and Gualerzi, C.O.},
title={Purpuromycin: An antibiotic inhibiting tRNA aminoacylation},
journal={RNA},
year={1997},
volume={3},
number={8},
pages={905-913},
note={cited By 27},
url={https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030753165&partnerID=40&md5=3ab611344e578c15f2b6ab4b909c8014},
affiliation={Laboratory of Genetics, Department of Biology MCA, University of Camerino, 62032 Camerino (MC), Italy; Lepetit Research Center, 21040 Gerenzano (VA), Italy; Petersburg Nuclear Physics Institute, Russian Academy of Sciences, 188350 Gathina, Russian Federation},
abstract={Purpuromycin, an antibiotic produced by Actinoplanes lanthinogenes, had been reported previously to inhibit protein synthesis. In the present report, we demonstrate that the mechanism of action of this antibiotic is quite novel in that it binds with fairly high affinity to all tRNAs, inhibiting their acceptor capacity. Although more than one molecule of purpuromycin is bound to each tRNA molecule, the inhibitory activity of this antibiotic was found to be selective for the tRNA acceptor function; in fact, after the aminoacylation step, purpuromycin was found to affect none of the other tested functions of tRNA (interaction with the ribosomal P- and A-sites and interaction with translation factors). Accordingly, purpuromycin was found to inhibit protein synthesis only when translation depended on the aminoacylation of tRNA and not when the system was supplemented with pre- formed aminoacyl-tRNAs. Because purpuromycin did not interfere with the ATP- PP(1) exchange reaction of the synthetase or with the initial interaction of the enzyme with its tRNA substrate, the basis for the inhibition of aminoacylation is presumably the formation of a nonproductive synthetase- tRNA complex in the presence of purpuromycin in which the tRNA is unable to be charged with the corresponding amino acid.},
author_keywords={Aminoacyl-tRNA synthetase;  Antibiotics;  Protein synthesis;  tRNA},
correspondence_address1={Gualerzi, C.O.; Laboratory of Genetics, Department of Biology MCA, University of Camerino, 62032 Camerino (MC), Italy; email: gualerzi@cambio.unicam.it},
issn={13558382},
coden={RNARF},
pubmed_id={9257649},
language={English},
abbrev_source_title={RNA},
document_type={Article},
source={Scopus},
}
Downloads: 0